BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2007
View Archived Issues
Snapshots: studies of vaccines for anthrax, plague, botulinum neurotoxin
Read More
Novel therapeutic agents for respiratory disorders described in recent patents
Read More
Recent patents disclose novel treatment options for gastrointestinal disorders
Read More
LCTA-1246: an anthracyclinone with cytotoxicity against MDR and p53-/- cancer cells
Read More
HIV-1 vaccine NYVAC-B safe and immunogenic in phase I study
Read More
GSK-364735 well tolerated in double-blind pharmacokinetic study
Read More
Studies show feasibility of dapivirine delivery via intravaginal rings
Read More
Study suggests HspE7 is effective for carcinoma in situ of the cervix
Read More
MVA-nef vaccine shows promise in phase II study
Read More
Recent GSK patents impart novel therapeutic agents for substance abuse
Read More
Novel TGF-beta type I receptor inhibitor shows potent antitumor activity in murine mesothelioma
Read More
SCOLR collaborates with BioCryst on oral formulation of peramivir
Read More
Bio-Bridge Science signs collaboration
Read More
New insights into novel mechanisms of action of HuMax-EGFr
Read More
Apogenix awarded German grant to study APG-101 for spinal cord injuries
Read More
TopoTarget in-licenses Zemab
Read More
T-705 begins clinical development in U.S. for influenza
Read More
Takeda to acquire Paradigm Therapeutics
Read More
Depomed seeks clearance to begin phase II studies of Gabapentin GR
Read More
Alethia and Biosite to develop antibodies for use in ovarian cancer
Read More
Daclizumab meets primary endpoint in phase II relapsing MS study
Read More
Outcome of Inflazyme's review of phase IIb asthma findings with IPL-512602
Read More
Revised trial design for phase IIb study of bevirimat
Read More
Phase II traumatic brain injury trial with anatibant begins enrollment
Read More
USAN approves voclosporin as generic name for ISA-247
Read More
Antitumor activity seen in phase Ib/II trial of CTCE-9908
Read More
Infuse Bone Graft approved for oral maxillofacial and dental regeneration
Read More
Tykerb approved in combination with Xeloda for breast cancer
Read More
